23-seleno-25-homotaurocholic acid has been researched along with Biliary Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baisini, O; Benini, F; De Tavonatti, MG; Lanzarotto, F; Lanzini, A; Mora, A; Panarotto, B; Scalia, S | 1 |
| de Caestecker, JS; Jazrawi, RP; Joseph, AE; Maxwell, JD; Nisbett, JA; Northfield, TC | 1 |
2 other study(ies) available for 23-seleno-25-homotaurocholic acid and Biliary Cirrhosis
| Article | Year |
|---|---|
Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.
Topics: Adult; Aged; Bile Acids and Salts; Cholagogues and Choleretics; Female; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis, Biliary; Middle Aged; Selenium Radioisotopes; Taurine; Taurocholic Acid; Ursodeoxycholic Acid | 2003 |
Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Female; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Selenium Radioisotopes; Taurocholic Acid | 1995 |